The U.S. Food and Drug Administration (FDA) has granted Vascular Perfusion Solutions, Inc. (VPS) a Breakthrough Device Designation for its groundbreaking VP.S Encore™ oxygenated perfusion cardiac ...
SAN ANTONIO--(BUSINESS WIRE)--Vascular Perfusion Solutions, Inc. (VPS) has received its first donated human heart for research through a partnership with Texas Organ Sharing Alliance (TOSA). VPS is ...
The research team led by Professors Young Eun Jang and Jung Bin Park from the Department of Anesthesiology and Pain Medicine ...
The New York University School of Medicine and collaborators found that capillary-associated macrophages in skin decline with ...
Melanoma incidence in the United States has increased during recent decades to an estimated number of 76,100 new cases in 2014, 1 comprising 4.6% of all new cancer cases. In approximately 5% to 8% of ...
SAN DIEGO--(BUSINESS WIRE)--Trestle Biotherapeutics, Inc., today announced a research collaboration with Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing ...
Findings published in Biological Psychiatry point to new therapeutic pathways to protect this at-risk population from heart failure and improve life expectancy Despite accumulating evidence that ...
"Vascular diseases afflict hundreds of millions of people in the world," said Chang-Hyun Gil, MS, PhD, a postdoctoral fellow in the Department of Surgery and co-first author of the study. "In this ...
In a series of studies that volleyed between large databases and research in zebrafish, Vanderbilt investigators have discovered a link between vascular biology and eye disease. The research uncovered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback